Pulmonary circulation : diseases and their treatment / edited by Andrew J. Peacock, Robert Naeije, Lewis J. Rubin.
Saved in:
Online Access: |
Full Text (via Taylor & Francis) |
---|---|
Other Authors: | , , |
Other title: | Pulmonary circulation (Peacock) |
Format: | eBook |
Language: | English |
Published: |
Boca Raton : CRC Press,
[2016]
|
Edition: | Fourth edition. |
Subjects: |
Table of Contents:
- Front Cover; Dedication; Contents; Preface; Contributors; Part 1: Physiology and Pathophysiology of Pulmonary Circulation and Right Heart; 1. Evolution of the pulmonary circulation and the right heart; 2. Pulmonary vascular function; 3. Gas exchange; 4. Right ventricular function; 5. Heart-lung interactions; Part 2: Pathobiology of Pulmonary Vascular Disease and Right Ventricular Failure; 6. Pathology of pulmonary vascular diseases; 7. Pathobiology of pulmonary hypertension; 8. Pathobiology of right ventricular failure; Part 3: Clinical Assessment of Pulmonary Hypertension.
- 9. Clinical features10. Echocardiography; 11. Imaging and pulmonary hypertension: chest radiography, ventilation-perfusion scintigraphy, and computed tomography; 12. Imaging: emerging modalities (magnetic resonance and nuclear imaging); 13. Exercise testing in pulmonary hypertension; 14. Clinical assessment of PH: biomarkers; 15. Cardiac catheterization; 16. Classification of pulmonary hypertension; Part 4: Group 1: Pulmonary Arterial Hypertension; 17. Idiopathic pulmonary arterial hypertension; 18. Heritable pulmonary hypertension.
- 19. Pulmonary arterial hypertension associated with drugs and toxins20. Pulmonary arterial hypertension associated with connective tissue diseases; 21. Portopulmonary hypertension; 22. Pulmonary arterial hypertension associated with HIV infection; 23. Pulmonary hypertension related to congenital systemic-to-pulmonary shunts; 24. Schistosomiasis; 25. Pulmonary hypertension in pregnancy; 26. Pulmonary venoocclusive disease and pulmonary capillary hemangiomatosis; 27. Pulmonary arterial hypertension registries; Part 5: Drug and Nondrug Treatment of Group 1 Pulmonary Arterial Hypertension.
- 28. Conventional medical therapies: supportive therapies and general clinical care measures29. Calcium channel blockers in the treatment of pulmonary arterial hypertension; 30. Prostacyclins; 31. Endothelin receptor antagonists; 32. Phosphodiesterase type-5 inhibitors; 33. Soluble guanylate cyclase stimulators and activators; 34. Rehabilitation; 35. Combination therapy for pulmonary arterial hypertension; 36. Atrial septostomy and Potts procedure; 37. Lung transplantation for pulmonary arterial hypertension including bridging to transplantation.
- 38. Future of pulmonary arterial hypertension therapyPart 6: Group 2: Pulmonary Hypertension Associated with Left Heart Conditions; 39. World Health Organization pulmonary hypertension group 2: pulmonary hypertension due to left heart disease; 40. Diagnosis and clinical relevance of pulmonary hypertension secondary to mitral or aortic valve diseases or congenital left-sided; 41. Treatment of pulmonary hypertension in left heart disease; Part 7: Group 3: Pulmonary HypertensIon Associated with Hypoxia, Hypoventilation, and Lung Disease; 42. Chronic high-altitude exposure.